Inhaltspezifische Aktionen

Area A

Pulmonary circulation, aberrant remodeling in PH and design of reverse remodeling treatment concepts

A01

FoxO transcription factors in PH: critical integrators of multiple signaling pathways driving pulmonary vascular and right ventricular remodeling.

A02

Deciphering the role of BMP9-BMP10 and YAP-TEAD signaling in vascular smooth muscle heterogeneity and pulmonary hypertension

A04

Origin and fate of vascular myofibroblasts and smooth muscle cells during pulmonary vascular remodeling and reverse remodeling

A05

Regulatory network of histone modifications in human pulmonary arterial hypertension.

A06

Sensing and signaling events underlying development and recovery of hypoxia-induced pulmonary hypertension

A07

iNOS- and NoxO1-based redox signaling in chronic obstructive pulmonary disease (COPD) associated PH – pathomechanisms and therapeutic exploitation

A08

Kinase signaling driving “pseudo-malignant” lung vascular remodeling – therapeutic exploitation

A09

Deep phenotyping combined with genomic, proteomic and metabolomic analyses in Kyrgyz highlanders – association with high altitude adaptation

A10N

Inflammatory lung microenvironment in lung cancer-associated pulmonary hypertension – the role of macrophages